Pseudoprogression as a prognostic biomarker in glioblastoma patients
Background: Pseudoprogression (PsP) has been reported as a predictor of a better prognosis in glioblastoma patients. However, other authors have failed to observe an improvement in overall survival (OS) in PsP patients. Thereby, we aimed to investigate the prognostic significance of PsP in glioblast...
| Autor principal: | |
|---|---|
| Formato: | masterThesis |
| Idioma: | eng |
| Publicado em: |
2022
|
| Assuntos: | |
| Texto completo: | https://hdl.handle.net/10216/141999 |
| País: | Portugal |
| Oai: | oai:repositorio-aberto.up.pt:10216/141999 |